← Back to Search

Integrative Medicine at Home (IM@Home) for Cancer (IMPROVE Trial)

N/A
Recruiting
Led By Jun Mao, MD, MSCE
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥ 18 years or older
Worst fatigue over the last 7 days rated 4 or greater on (0-10 scale)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

IMPROVE Trial Summary

This trial will test whether the IM@Home program can help reduce patients' symptoms and improve their satisfaction with treatment for their disease.

Who is the study for?
This trial is for adults over 18 with certain cancers (like head and neck, lung, gynecologic, or melanoma) who are currently undergoing treatment or have recently finished radiotherapy. They should be experiencing fatigue and have a life expectancy of more than six months. Participants must speak English and not have cognitive impairments that affect communication.Check my eligibility
What is being tested?
The study is testing the IM@Home program to see if it can ease symptoms like tiredness, pain, or sleep issues in cancer patients. It involves virtual group classes that use mind-body practices such as mental focus exercises, controlled breathing, and body movements.See study design
What are the potential side effects?
Since IM@Home is a non-invasive program focusing on relaxation techniques rather than medication or surgery, significant side effects are not expected. However, participants may experience varying levels of comfort with the activities.

IMPROVE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have experienced significant fatigue, rating it 4 or higher in the past week.
Select...
I have been diagnosed with cancer in my head, neck, chest, reproductive organs, skin, or breast.
Select...
I am currently undergoing cancer treatment or finished radiotherapy within the last 4 weeks.
Select...
I am able to care for myself but may not be able to do active work.

IMPROVE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Average Fatigue Severity from the Brief Fatigue Inventory (BFI)

IMPROVE Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: IM@HomeExperimental Treatment1 Intervention
Participants with head and neck tumors, thoracic tumors, gynecological tumors, melanoma, or breast cancer
Group II: Enhanced usual carePlacebo Group1 Intervention
Participants with head and neck tumors, thoracic tumors, gynecological tumors, melanoma, or breast cancer

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,930 Previous Clinical Trials
597,178 Total Patients Enrolled
Jun Mao, MD, MSCEPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
9 Previous Clinical Trials
1,814 Total Patients Enrolled

Media Library

Enhanced usual care 2023 Treatment Timeline for Medical Study. Trial Name: NCT05053230 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining vacancies for participants in this clinical trial?

"Affirmative. According to information hosted on clinicaltrials.gov, this experiment is still recruiting participants and was originally posted on September 20th 2021. The trial aims to enrol 200 patients from 7 different medical hubs."

Answered by AI

What is the upper limit to participant enrollment in this trial?

"Absolutely. According to clinicaltrials.gov, this medical experiment was initially posted on September 20th 2021 and is presently recruiting for 200 participants from 7 different sites. It has been recently updated on August 9th 2022."

Answered by AI

How many healthcare facilities are participating in this clinical trial?

"At present, there are 7 sites where this clinical trial can be found. These cities include Harrison, Montvale and Middletown alongside 4 other places. Participants should consider the closest site to them in order to minimize their necessary travel for participation."

Answered by AI
~28 spots leftby Sep 2024